| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01971460 |
| P698 | PubMed publication ID | 6436052 |
| P50 | author | Erik Gylfe | Q43049285 |
| P2093 | author name string | J Sehlin | |
| B Hellman | |||
| B Täljedal | |||
| P2860 | cites work | On the Possible Role of Thiol Groups in the Insulin-Releasing Action of Mercurials, Organic Disulfides, Alkylating Agents, and Sulfonylureas | Q28320917 |
| Inhibition of glucose-induced release of insulin by aldose reductase inhibitors | Q34708157 | ||
| Effect of glibenclamide on the osmotic resistance of pancreatic beta-cells | Q36605047 | ||
| The mechanism of sulfonylurea stimulation of insulin release. | Q38355789 | ||
| Potentiating effects of drugs on the binding of glibenclamide to pancreatic beta cells | Q38361033 | ||
| Effects of various modifiers of insulin release on the lanthanum-nondisplaceable45ca2+ uptake by isolated pancreatic islets | Q40049071 | ||
| Insulin secretion in diabetes mellitus | Q40302183 | ||
| On insulin secretion | Q40313938 | ||
| Effect of glucose on K+handling by pancreatic islets | Q40828194 | ||
| D-Glucose inhibits potassium efflux from pancreatic islet cells | Q40850833 | ||
| Uptake of tolbutamide by islets of Langerhans and other tissues | Q40991688 | ||
| Stimulus-secretion coupling of glucose-induced insulin release. XXIX. Regulation of 86Rb+ efflux from perfused islets | Q41002036 | ||
| Transport of rubidium and sodium in pancreatic islets | Q41514972 | ||
| Insulinotropic effects of hypoglycaemic and hyperglycaemic sulphonamides: The ionophoretic hypothesis | Q41549286 | ||
| L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase | Q41614642 | ||
| Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose | Q41618502 | ||
| The pentose cycle and insulin release in mouse pancreatic islets | Q41838893 | ||
| Interrelationship of islet metabolism, adenosine triphosphate content and insulin release | Q42105569 | ||
| Synergistic effects of hypoglycaemic sulphonylureas and antibiotic ionophores upon calcium translocation | Q42633250 | ||
| Effects of glucose and other modifiers of insulin release on the oxidative metabolism of amino acids in micro-dissected pancreatic islets | Q42922523 | ||
| Glucose metabolism in mouse pancreatic islets | Q42925548 | ||
| The kinetics of electrical activity of beta cells in response to a "square wave" stimulation with glucose or glibenclamide | Q43433034 | ||
| The pancreatic beta-cell recognition of insulin secretagogues. Inhibitory effects of a membrane probe on the islet uptake and insulin-releasing action of glibenclamide | Q43527081 | ||
| Is there a common beta cell insulin compartment stimulated by glucose and tolbutamide? | Q43600937 | ||
| The biophysical effects of insulin-releasing agents on islet cells | Q44091608 | ||
| Ionic effects on the uptake of sulfonylurea (glibenclamide) by pancreatic islets | Q44762937 | ||
| The pancreatic β-cell recognition of insulin secretagogues. II. Site of action of tolbutamide | Q47736543 | ||
| Specific receptors for sulfonylureas in brain and in a B-cell tumor of the rat | Q48966318 | ||
| Role of cyclic AMP in insulin release evoked by glucose and other secretagogues. | Q52231354 | ||
| Ionophoretic activity of hypoglycemic sulfonylureas | Q53734336 | ||
| Role of glucose as a regulator and precursor of amino acids in the pancreatic beta-cells. | Q53848688 | ||
| The pancreatic -cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas. | Q54105575 | ||
| Requirement for calcium ion in insulin secretion by the perfused rat pancreas. | Q54282379 | ||
| Adenosine Triphosphate Levels of Mammalian Pancreatic B Cells after Stimulation with Glucose and Hypoglycemic Sulfonylureas | Q54361249 | ||
| Glucose-induced decrease in Rb+ permeability in pancreatic β cells | Q59084984 | ||
| Depolarization-independent net uptake of calcium into clonal insulin-releasing cells exposed to glucose | Q60032740 | ||
| Uptake of glibornuride by microdissected pancreatic islets | Q67296577 | ||
| Comparison of the effects of leucines, non-metabolizable leucine analogues and other insulin secretagogues on the activity of glutamate dehydrogenase | Q67855971 | ||
| Factors affecting the uptake of glibenclamide in microdissected pancreatic islets rich in beta-cells | Q68342154 | ||
| The Stimulus-Secretion Coupling of Glucose-Induced Insulin Release VIII. Combined Effects of Glucose and Sulfonylureas | Q69175744 | ||
| The stimulus-secretion coupling of glucose-induced insulin release XII. Effects of diazoxide and gliclazide upon45calcium efflux from perifused islets | Q69258165 | ||
| Acid Amyloglucosidase and Carbohydrate Regulation - III. The Induction of Sulphonylurea-Stimulated Insulin Release and its Dependence on Intracellular Monoamines | Q69380224 | ||
| Properties of ionophores with broad range cation selectivity | Q69580559 | ||
| Electrical activity in pancreatic islet cells | Q69845749 | ||
| Action of some hypoglycaemic sulphonylureas on the oxygen consumption of isolated pancreatic islets of mice | Q69894220 | ||
| Energy Metabolism in Pancreatic Islets of Rats: Studies with Tolbutamide and Hypoxia | Q69946345 | ||
| Tolbutamide stimulation of 45Ca fluxes in microdissected pancreatic islets rich in beta-cells | Q70183865 | ||
| Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells | Q70245055 | ||
| Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids | Q70309196 | ||
| Transport of Pr3+ by hypoglycemic sulfonylureas across liposomal membranes | Q70428165 | ||
| Effect of a hypoglycaemic sulphonylurea (HB419) and a non-metabolizable amino acid (BCH) on the insulin release and endogenous substrate metabolism of rat pancreatic islets | Q70436043 | ||
| Binding of hypoglycaemic sulphonylureas to an artificial phospholipid bilayer | Q70470826 | ||
| Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules | Q70548666 | ||
| Calcium transport in liposomes containing hypoglycemic and hyperglyemic sulfonamides | Q71428372 | ||
| Modalities of gliclazide-induced Ca2+ influx into the pancreatic B-cell | Q71462687 | ||
| Opposite effects of hypoglycemic and hyperglycemic sulfonamides upon ionophore-mediated calcium transport | Q71511027 | ||
| Changes in glucose-stimulated insulin secretion after long-term treatment of C57BL mice with glibenclamide | Q71528481 | ||
| Long-term effects of glibenclamide on the insulin production, oxidative metabolism and quantitative ultrastructure of mouse pancreatic islets maintained in tissue culture at different glucose concentrations | Q71540171 | ||
| Are Cl- mechanisms in mouse pancreatic islets involved in insulin release? | Q71583942 | ||
| Differences between the effect of tolbutamide and Ca2+-ionophores on Ca2+ efflux from pancreatic beta-cells | Q71631023 | ||
| Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets | Q72129897 | ||
| Metabolic, cationic and secretory effects of hypoglycemic sulfonylureas in pancreatic islets | Q72145797 | ||
| Carbutamide stimulation of glutamic dehydrogenase activity in the pancreatic β cells from obese-hyperglycemic mice | Q72314196 | ||
| Effect of hypoglycemic sulfonylureas on Ca2+ fluxes across lipid bilayers | Q72732454 | ||
| Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in β-cell-rich pancreatic islets | Q72809187 | ||
| Levels of α-Ketoglutarate and Glutamate in Stimulated Pancreatic β-Cells | Q93833034 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1126-1134 | |
| P577 | publication date | 1984-10-01 | |
| P1433 | published in | Experientia | Q21385347 |
| P1476 | title | Interaction of sulfonylurea with the pancreatic B-cell | |
| P478 | volume | 40 |
| Q33554980 | ATP-sensitive K+ channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone |
| Q44046827 | ATP-sensitive K-channels in HIT T15 beta-cells studied by patch-clamp methods, 86Rb efflux and glibenclamide binding |
| Q42173668 | An inhibitory role for polyamines in protein kinase C activation and insulin secretion in mouse pancreatic islets |
| Q69913208 | Beta-cell cytoplasmic Ca2+ balance as a determinant for glucose-stimulated insulin release |
| Q42856428 | Biosynthesis of insulin secretory granule membrane proteins. Control by glucose. |
| Q39504068 | Calcium transport in pancreatic beta-cells: implications for glucose regulation of insulin release |
| Q46790732 | Changes of membrane currents in cardiac cells induced by long whole-cell recordings and tolbutamide |
| Q57504439 | Characterization of sulfonylurea receptors in isolated human pancreatic islets |
| Q54128043 | Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells. |
| Q38351945 | Direct measurements of increased free cytoplasmic Ca2+ in mouse pancreatic beta-cells following stimulation by hypoglycemic sulfonylureas |
| Q42857185 | Effect of perchlorate on calcium uptake and insulin secretion in mouse pancreatic islets |
| Q42465957 | Effects of porcine diazepam-binding inhibitor on insulin and glucagon secretion in vitro from the rat endocrine pancreas |
| Q42848672 | Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line |
| Q54107466 | Effects of verapamil and nifedipine on gliclazide-induced increase in cytosolic free Ca2+ in pancreatic islet cells. |
| Q35755181 | Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic beta-cells |
| Q69551659 | How do sulfonylureas approach their receptor in the B-cell plasma membrane? |
| Q41878159 | Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. |
| Q45835469 | Insulin secretory responses of a clonal cell line of simian virus 40-transformed B cells |
| Q70289261 | Internalization of 3H-glibenclamide in pancreatic islet cells |
| Q69972595 | Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide |
| Q44961703 | New mechanisms for sulfonylurea control of insulin secretion |
| Q44273170 | Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells |
| Q70222704 | Oral hypoglycemic agents |
| Q38631248 | Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update |
| Q38691347 | Pharmacology and regulation of ATP-sensitive K+ channels. |
| Q33992531 | Pharmacotherapy of type 2 diabetes mellitus |
| Q68922788 | Regulation of energy metabolism in pancreatic islets by glucose and tolbutamide |
| Q35043029 | Relationships between the Na(+)/K(+) pump and ATP and ADP content in mouse pancreatic islets: effects of meglitinide and glibenclamide |
| Q40078304 | Stimulus-secretion coupling in the pancreatic B-cell: concluding remarks |
| Q44119980 | Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect |
| Q51314532 | The effect of glibenclamide on insulin secretion at normal glucose concentrations. |
| Q44956244 | The oral hypoglycemic agent, U-56324, inhibits the activity of ATP-sensitive potassium channels in cell-free membrane patches from cultured mouse pancreatic B-cells |
| Q39662366 | The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs |
| Q45163742 | Tolbutamide potentiates the volume-regulated anion channel current in rat pancreatic beta cells |
Search more.